T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells

被引:395
|
作者
Fahlén, L
Read, S
Gorelik, L
Hurst, SD
Coffman, RL
Flavell, RA
Powrie, F
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
[3] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[4] Dynavax Technol Corp, Albany, CA 94710 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2005年 / 201卷 / 05期
基金
英国惠康基金;
关键词
D O I
10.1084/jem.20040685
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T (T reg) cells play a pivotal role in control of the immune response. Transforming growth factor-beta (TGF-beta) has been shown to be required for T reg cell activity; however, precisely how it is involved in the mechanism of suppression is poorly understood. Using the T cell transfer model of colitis, we show here that CD4(+)CD45RB(high) T cells that express a dominant negative TGF-beta receptor type II (dnT beta RII) and therefore cannot respond to TGF-beta, escape control by T reg cells in vivo. CD4(+)CD25(+) T reg cells from the thymus of dnT beta RII mice retain the ability to inhibit colitis, suggesting that T cell responsiveness to TGF-beta is not required for the development or peripheral function of thymic-derived T reg cells. In contrast, T reg cell activity among the peripheral dnT beta RII CD4(+)CD25(+) population is masked by the presence of colitogenic effector cells that cannot be suppressed. Finally, we show that CD4(+)CD25(+) T reg cells develop normally in the absence of TGF-beta 1 and retain the ability to suppress colitis in vivo. Importantly, the function of TGF-beta 1(-/-) T reg cells was abrogated by anti-TGF-beta monoclonal antibody, indicating that functional TGF-beta can be provided by a non-T reg cell source.
引用
收藏
页码:737 / 746
页数:10
相关论文
共 50 条
  • [41] Isolation of CD4+CD25+ regulatory T cells for clinical trials
    Hoffmann, P
    Boeld, TJ
    Eder, R
    Albrecht, J
    Doser, K
    Pieshka, B
    Dada, A
    Niemand, C
    Assenmacher, M
    Orsó, E
    Andreesen, R
    Holler, E
    Edinger, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (03) : 267 - 274
  • [42] TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling
    Oida, Takatoku
    Xu, Lili
    Weiner, Howard L.
    Kitahi, Atsushi
    Strober, Warren
    JOURNAL OF IMMUNOLOGY, 2006, 177 (04): : 2331 - 2339
  • [43] Prevention of autoimmune disease by CD4+CD25+ regulatory T cells
    Van Driel, IR
    Zwar, TD
    Allen, S
    Read, S
    Gleeson, PA
    TISSUE ANTIGENS, 2005, 66 (05): : 574 - 575
  • [44] The effects of antibody treatment on regulatory CD4+CD25+ T cells
    Yi, Huanfa
    Zhang, Jialin
    Zhao, Yong
    TRANSPLANT IMMUNOLOGY, 2008, 19 (01) : 37 - 44
  • [45] CD4+CD25+ regulatory T cells in human lupus erythematosus
    Annegret Kuhn
    Stefan Beissert
    Peter H. Krammer
    Archives of Dermatological Research, 2009, 301 : 71 - 81
  • [46] CD4+CD25+ regulatory T cells in human lupus erythematosus
    Kuhn, Annegret
    Beissert, Stefan
    Krammer, Peter H.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 71 - 81
  • [47] CD4+CD25+ regulatory T cells in rheumatoid arthritis.
    van Amelsfort, JMR
    Jacobs, KMG
    Bijlsma, JWJ
    Lafeber, FPJ
    Taams, LS
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S486 - S486
  • [48] Role of CD4+CD25+ regulatory T cells in corneal neovascularization
    Usui, T
    Yamagami, S
    Kishimoto, S
    Mimura, T
    Ono, K
    Yokoo, S
    Amano, S
    Ishida, S
    Usui, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [49] The role of CD4+CD25+ regulatory T cells in viral infections
    Vahlenkamp, TW
    Tompkins, MB
    Tompkins, WAF
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2005, 108 (1-2) : 219 - 225
  • [50] The role of CD4+CD25+ regulatory T cells in Leishmania infection
    Belkaid, Y
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (06) : 875 - 885